Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CYTR

CytRx

$1.88

-0.01 (-0.53%)

09:09
11/17/17
11/17
09:09
11/17/17
09:09
Hot Stocks
CytRx regains Nasdaq listing compliance »

CytRx announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
CYTR

CytRx

$2.00

0.13 (6.95%)

09:04
11/13/17
11/13
09:04
11/13/17
09:04
Hot Stocks
CytRx provides business update, announces new shareholder initiatives »

CytRx provided a business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTR

CytRx

$2.16

-0.05 (-2.26%)

09:04
11/06/17
11/06
09:04
11/06/17
09:04
Hot Stocks
CytRx's drug development activities to be led by Hurley Consulting Associates »

CytRx announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTR

CytRx

$0.33

-0.0088 (-2.60%)

09:05
10/31/17
10/31
09:05
10/31/17
09:05
Hot Stocks
CytRx announces 1-for-6 reverse stock split »

CytRx announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTR

CytRx

$0.34

-0.0199 (-5.56%)

12:49
10/30/17
10/30
12:49
10/30/17
12:49
Periodicals
CytRx CEO deflects blame for performance, Feuerstein says »

Steve Kriegsman, chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTR

CytRx

$0.36

0.013 (3.77%)

14:18
10/27/17
10/27
14:18
10/27/17
14:18
Hot Stocks
CytRx stockholders approve reverse stock split »

CytRx announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
CYTR

CytRx

$0.38

-0.0142 (-3.64%)

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Conference/Events
CytRx to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CYTR

CytRx

$0.38

-0.0142 (-3.64%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
CytRx to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CYTR

CytRx

$0.38

-0.0142 (-3.64%)

18:29
10/16/17
10/16
18:29
10/16/17
18:29
Hot Stocks
CytRx granted listing extension pending results of stockholder vote »

CytRx 's request for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CYTR

CytRx

$0.42

0.006 (1.47%)

09:06
10/12/17
10/12
09:06
10/12/17
09:06
Hot Stocks
CytRx: NantWorks to submit IND applications including aldoxorubicin »

CytRx highlighted that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.